Search：
All Dates (UTC+8)：
- All
- 2025-06-06 [Friday]
- 2025-06-07 [Saturday]
- 2025-06-08 [Sunday]
All Rooms：
- All
- Watson Auditorium
- Exhibition Area - II
- Exhibition Area - III
- Meeting room - M1
- Meeting Room F1
- Meeting Room M2
- Meeting Room M6
2025-06-07 Saturday
Exhibition Area - II (UTC+8) 2025-06-07 Local Time
12:30-13:30 (UTC+8)
12:30-13:30
Local Time | Satellite Symposium-1
13:30-14:30 (UTC+8)
13:30-14:30
Local Time | Intersections: Evidence-Based Strategy for Curing Hepatocellular Carcinoma
| NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|---|
| 1 | 13:30-13:42 | 13:30-13:42 | Symposium |
How to Provide More Surgical Opportunities for Patients with HCC Using Minimal Invasive Methods to Increase the Remnant Liver Volume |
Lian-Xin Liu | The First Affiliated Hospital of University of Science and Technology of China, China |
| 2 | 13:42-13:54 | 13:42-13:54 | Symposium |
SIRT: Catheter Optimization = Dose Optimization |
David M. Liu | Vancouver General Hospital, Canada |
| 3 | 13:54-14:06 | 13:54-14:06 | Symposium |
Role of Y90 Radioembolization in Treatment of Large HCCs |
Rickie Lik-Fai Cheng | Princess Margaret Hospital, Hong Kong |
| 4 | 14:06-14:18 | 14:06-14:18 | Panelist |
Panelists
Tao Peng
The First Affiliated Hospital of Guangxi Medical University, China /
Lian-Xin Liu
The First Affiliated Hospital of University of Science and Technology of China, China /
David M. Liu
Vancouver General Hospital, Canada /
Rickie Lik-Fai Cheng
Princess Margaret Hospital, Hong Kong
|
||
14:30-15:30 (UTC+8)
14:30-15:30
Local Time | Interventional Oncology and Immuno-oncology for Hepatocellular Carcinoma
| NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|---|
| 1 | 14:30-14:42 | 14:30-14:42 | Symposium |
Combining TACE with Checkpoint Inhibitors for Intermediate-stage HCC |
David C. Madoff | Yale School of Medicine, USA |
| 2 | 14:42-14:54 | 14:42-14:54 | Symposium |
How to Select 2nd-line Systemic Therapy in Advanced-stage HCC? |
Masatoshi Kudo | Kindai University Faculty of Medicine, Japan |
| 3 | 14:54-15:06 | 14:54-15:06 | Symposium |
First-line TACE with ICIs and VEGFis or TKIs for Intermediate-stage HCC: A Target Trial Emulation Study |
Hai-Dong Zhu | Zhongda Hospital, Southeast University, China |
| 4 | 15:06-15:18 | 15:06-15:18 | Panelist |
Panelists
Wan-Guang Zhang
Hepatic Surgery Center,Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China /
David C. Madoff
Yale School of Medicine, USA /
Masatoshi Kudo
Kindai University Faculty of Medicine, Japan /
Hai-Dong Zhu
Zhongda Hospital, Southeast University, China
|
||
16:00-17:00 (UTC+8)
16:00-17:00
Local Time | A Forward March: Updates in Cholangiocellular Carcinoma
| NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|---|
| 1 | 16:12-16:24 | 16:12-16:24 | Symposium |
Hepatopancreatoduodenectomy for Widespread Hilar Cholangiocarcinoma |
Kiyoshi Hasegawa | Graduate School of Medicine, The University of Tokyo Hospital, Japan |
| 2 | 16:24-16:36 | 16:24-16:36 | Symposium |
TBD |
Feng Shen | Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China |
| 3 | 16:36-16:48 | 16:36-16:48 | Symposium |
Intervention for Biliary Malignancy |
Seung Boo Yang | Nowon Eulji University Hospital, Korea |
| 4 | 16:48-17:00 | 16:48-17:00 | Panelist |
Panelists
Hai-Tao Zhao
Peking Union Medical College Hospital, China /
Kiyoshi Hasegawa
Graduate School of Medicine, The University of Tokyo Hospital, Japan /
Feng Shen
Third Affiliated Hospital of Naval Medical University (Shanghai Oriental Hepatobiliary Surgery Hospital), China /
Seung Boo Yang
Nowon Eulji University Hospital, Korea
|
||
17:00-18:00 (UTC+8)
17:00-18:00
Local Time | Inovation and Translation on Tumor Diagnose and Treatments
| NO. | Beijing Time (UTC+8) | Local Time | Type | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|---|
| 1 | 17:00-17:12 | 17:00-17:12 | Symposium |
Percutaneous Biliary Metallic Stent Insertion in Patients with Malignant Duodenobiliary Obstruction: Outcomes and Factors Influencing Biliary Stent Patency |
Hyun Ki Yoon | Asan Medical Center, University of Ulsan College of Medicine, Korea |
| 2 | 17:12-17:24 | 17:12-17:24 | Symposium |
The Value of Integrated Angiography and CT Scan System for Oncologic Interventions |
Kiang Hiong Tay | Singapore General Hospital SingHealth Duke-NUS Academic Medical Centre, Singapore |
| 3 | 17:24-17:36 | 17:24-17:36 | Symposium |
The New Age of Molecular Imaging and Impact on HCC Therapy |
David M. Liu | Vancouver General Hospital, Canada |
| 4 | 17:36-17:48 | 17:36-17:48 | Panelist |
Panelists
Kiang Hiong Tay
Singapore General Hospital SingHealth Duke-NUS Academic Medical Centre, Singapore /
Hyun Ki Yoon
Asan Medical Center, University of Ulsan College of Medicine, Korea /
David M. Liu
Vancouver General Hospital, Canada
|
||